Can we get rid of neutralizing antibodies against interferon-β?
Buttmann
M
M
Toyka
K V
KV
D057134:Antibodies, Neutralizing / Q000096:biosynthesis / Q000097:blood* / Q000378:metabolism; D001666:Binding Sites, Antibody / Q000187:drug effects / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016899:Interferon-beta / Q000276:immunology* / Q000378:metabolism* / Q000627:therapeutic use; D008775:Methylprednisolone / Q000008:administration & dosage; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology* / Q000378:metabolism
D057134:Antibodies, Neutralizing; D007166:Immunosuppressive Agents; D016899:Interferon-beta; D008775:Methylprednisolone